Capsugel & Orkila Egypt's Partnership Announcement
Mar 26, 2018
Orkila and Lonza's Capsule Delivery Solutions Announce Exclusive Agency Partnership in Egypt.
Beirut, Lebanon, March 2018 - Orkila is pleased to announce a new exclusive agency agreement with Capsule Delivery Solutions, part of Lonza Pharma & Biotech, allowing Orkila to promote and sell their whole Capsugel® capsule range in Egypt.
“This agreement is an important part of our business strategy to drive growth and streamline our channel to market," said Philippe Azzi, Capsule Delivery Solutions’ Territory Sales Manager for Lonza. "By leveraging Orkila's extensive logistics network and deep industry expertise, we will be able to serve our Egyptian customers faster and more efficiently throughout the country.”
Serge Yeterian, Orkila’s Head of Life Sciences, added: “Capsugel represents more than 85 years of experience, excellence and dedication to the pharmaceutical and nutraceutical industries. The inclusion of Capsugel® products in Orkila’s portfolio will further enhance our value-added product portfolio in Egypt. We are confident that we will make the most of this new partnership for the benefit of both our customers and Lonza’s Capsule Delivery Solutions.”
Orkila Group is a multinational leading distributor of specialty chemicals in Africa and the Middle East, covering a wide range of sectors within the Food, Life Sciences and Performance Business Units.
Headquartered in Beirut, the group operates a distribution network selling in more than 35 countries. Located in 20 regional centers, our business is supported by a sales and marketing organization that enables us to serve customers throughout the region. Orkila offers a flexible and highly reactive service through its modern and efficient supply facilities in the key markets of the region.
Being aware of today’s customers’ and regulatory requirements, Orkila operates in compliance with international standards such as ISO 9001:2015 and the Good Distribution Practices.
About Orkila’s Pharmaceutical Sector
Orkila has a wide-ranging portfolio of pharmaceutical ingredients, including a large spectrum of excipients, pharma-grade solvents, flavours, desiccants and high quality Active Pharmaceutical Ingredients. Through local certified warehouses and group centralization, Orkila serves customers to the best of their needs in all of the available dosage forms. More information about Orkila is available on www.orkila.com.
About Lonza's Capsule Delivery Solutions
Capsule Delivery Solutions, part of Lonza Pharma Biotech, is the global leader in capsules and encapsulation technology and designs. Their unique combination of science, engineering, formulation and capsule expertise enables customers to optimize the bioavailability, targeted delivery and overall performance of their products. More information about the Capsugel® product range is available on www.capsugel.com.
Lonza is one of the world’s leading and most-trusted suppliers to the pharmaceutical, biotech and specialty ingredients markets. As an integrated solutions provider, Lonza is boosting its value creation along and beyond the healthcare continuum with a strong focus on patient healthcare, consumer preventive healthcare and consumer's healthy environment.
With the recent Capsugel acquisition, Lonza now offers products and services from the custom development and manufacturing of active pharmaceutical ingredients to innovative dosage forms for the pharma and consumer health and nutrition industries.
Further information can be found at www.lonza.com.
For more details on Orkila and Lonza’s Capsule Delivery Solutions products, please contact Mr Ibraam Mansour at email@example.com or on the +20 2 24145738.